翻译尚未完成，当前显示原文。
Precision oncology and digitally enabled cancer care are transforming what it means to live with cancer. The number of people in Europe alive more than five years after a cancer diagnosis grew 41 percent between 2010 and 2020, to nearly 15 million. As science progresses, a growing number of advanced cancers could be managed as chronic diseases, like diabetes or hypertension. But many patients are only able to access innovative treatments as part of a clinical trial, and Europe’s share of global commercial trials has almost halved in a decade. Access to screening and advanced diagnostics also varies widely across the bloc.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。